Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of the study is to investigate the effect of stress on glucose tolerance during pregnancy.
The main objectives of the study are to investigate if various measures of stress (stressful life events, the perceived level of stress and the cortisol or copeptin concentrations) differ between pregnant women with and without gestational diabetes during the end of the second/beginning of the third trimester when presenting for their routine glucose tolerance testing.
Secondary objectives are the link between these different stress measures and the routinely measured fasting and stimulated glucose levels during the oral glucose tolerance test.
Hypotheses in this study, 3 primary hypotheses will be tested.
Secondary objectives:
1. To test the link between these stress measures and the fasting and stimulated glucose levels during the oral glucose tolerance test.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Women with gestational diabetes | Women with gestational diabetes diagnosed by clinically routine 75 g oral glucose tolerance testing | ||
| Women without gestational diabetes | Women without gestational diabetes diagnosed by clinically routine 75 g oral glucose tolerance testing |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Markers of stress | stress (stressful life events, the perceived level of stress and the cortisol or copeptin concentrations) | At assessment |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Pregnant women
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jardena J. Puder, MD | University of Lausanne | Study Director |
| Ji-Seon Kang | University of Lausanne | Principal Investigator |
| Yvan Vial, MD | University of Lausanne | Principal Investigator |
| Pr Ulrike Ehlert, PhD | University of Zurich | Principal Investigator |
| Ayala Borghini, PhD | University of Lausanne | Principal Investigator |
| Pedro Marques-Vidal, MD, PhD | University of Lausanne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Maternité CHUV, University of Lausanne | Lausanne | 1011 | Switzerland |
Not provided
| ID | Term |
|---|---|
| D016640 | Diabetes, Gestational |
| D001008 | Anxiety Disorders |
| D003919 | Diabetes Insipidus |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003920 | Diabetes Mellitus |
Not provided
Not provided
Not provided
Not provided
Not provided
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D001523 | Mental Disorders |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D010900 | Pituitary Diseases |